0001739614-20-000001.txt : 20200416 0001739614-20-000001.hdr.sgml : 20200416 20200415184352 ACCESSION NUMBER: 0001739614-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200416 DATE AS OF CHANGE: 20200415 EFFECTIVENESS DATE: 20200416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibrx, Inc. CENTRAL INDEX KEY: 0001739614 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 824257312 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-365106 FILM NUMBER: 20794714 BUSINESS ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 795-4220 MAIL ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001739614 Inhibrx, Inc. 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA CALIFORNIA 92037 (858) 759-1499 DELAWARE TENIUM THERAPEUTICS, INC. None Corporation true 2017 Mark Lappe c/o Inhibrx, Inc. 11025 N. Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Executive Officer Director Brendan Eckelman c/o Inhibrx, Inc. 11025 N. Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Executive Officer Director Jon Kayyem c/o Inhibrx, Inc. 11025 N. Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Director Doug Forsyth c/o Inhibrx, Inc. 11025 N. Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Director Judith Li c/o Inhibrx, Inc. 11025 N. Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Director Kelly Deck c/o Inhibrx, Inc. 11025 N. Torrey Pines Road, Suite 200 La Jolla CA CALIFORNIA 92037 Executive Officer Biotechnology Decline to Disclose 06b false 2020-04-06 false true true true true false 0 30000000 15000000 15000000 false 5 0 0 0 false Inhibrx, Inc. /s/ Mark Lappe Mark Lappe Chief Executive Officer 2020-04-15